Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 5/2002

01-06-2002 | Notas Clínicas

A case of biliary adenofibroma of the liver causing elevated serum CA 19-9 levels

Authors: Ana Lilia Garduño-López, Ricardo Mondragón-Sánchez, Rigoberto Bernal-Maldonado, Carlos A. Hinojosa-Becerril, Abelardo Meneses-García

Published in: Clinical and Translational Oncology | Issue 5/2002

Login to get access
Metadata
Title
A case of biliary adenofibroma of the liver causing elevated serum CA 19-9 levels
Authors
Ana Lilia Garduño-López
Ricardo Mondragón-Sánchez
Rigoberto Bernal-Maldonado
Carlos A. Hinojosa-Becerril
Abelardo Meneses-García
Publication date
01-06-2002
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 5/2002
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02732513

Other articles of this Issue 5/2002

Clinical and Translational Oncology 5/2002 Go to the issue

Sección Docente

Radioprotectors

Originales

A comparative study of HER2/neu amplification and overexpression using fluorescencein situ hybridization (FISH) and immunohistochemistry (IHC) in 101 breast cancer patients

Notas Clínicas

Masa pancreática como presentación de recaída de cáncer de pulmón no microcítico

Originales

Factors involved in morbidity and mortality of total gastrectomy for gastric cancer

Originales

Cisplatin-based chemotherapy and hyperfractionated radiotherapy for stage III non-small cell lung cancer: survival and patterns of failure after long follow-up

Revisiones

Prostate cancer and the androgen receptor gene
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits